Fucosidosis is a lysosomal storage disease which affects humans and English springer spaniel dogs. The disease is recessively inherited in both species and results from a deficiency of the enzyme a-Lfucosidase. We have recendy cloned and sequenced the canine fucosidase gene (EMBL sequence admission number X92448 (cDNA) and X92671-X92678 (individual exonic data)). The gene spans 12 kb and consists of eight exons. SSCP based mutation analysis of affected animals was carried out on the coding region of this gene both with exonic primers, and intronic primer pairs for each exon. A 14 base pair deletion of the cDNA was identified at the 3' end of exon 1 in fucosidosis affected animals. Surprisingly, PCR based genomic cloning of DNA from these animals showed an identical deletion in this DNA, ending at the start of intron 1. This change causes a frameshift and, in consequence, 25 novel codons are transcribed in exon 2 before the first of two adjacent premature stop codons is encountered. (JMed Genet 1996;33:284-288) 
The lysosomal storage disease fucosidosis has been described in humans' and also in pedigree The disease in the springer spaniel manifests as a mainly neurological syndrome with mixed motor and mental function deficits including progressive ataxia, proprioceptive difficulties, apparent blindness, change in temperament, dysphagia, dysphonia, and loss of learned behaviour.5 As the disease progresses there is a rapid deterioration in body condition with muscle wasting. Affected dogs die or are euthanased by 3 to 4 years of age. The canine disease has been likened to the delayed onset human form because dogs are clinically normal until 18 months of age. Thus, disease similarities have led to the use of springer spaniel dogs as models in bone marrow transplantation trials. 67 Both the canine and the human diseases are inherited as autosomal recessive conditions. Pedigree analysis of canine families suggests that a common British founder is present in all affected lines, including those in Australia which were derived from exported British breeding stock. Testing for carrier status in dogs has been conducted in the UK by analysis of enzyme activity.8 Heterozygotes should have enzyme activities that are approximately 50% of the control mean. The division between normal and heterozygous dogs is, however, often indistinct and a molecular description of the disease causing mutation would be valuable in allowing definitive designations of genotype within the springer spaniel population.
The cDNA for human oc-L-fucosidase (FUCAl) has been cloned,9 and the genomic organisation established.'0 In addition, most families with affected family members have had the molecular basis of the disease investigated. Early analyses described the obliteration of an EcoRI site in six patients from five fucosidosis families" 12 and the deletion of the last two exons at the 3' end of the gene.'3 As more patients are analysed, it has become clear that there is considerable mutational variety within the patient groups studied.""'9 Most of the mutations described involve single base substitutions or small deletions or insertions. One splice site mutation has been identified.'" No obvious mutation "hotspots" have so far been identified in human fucosidosis.
We have recently cloned and sequenced the canine gene for fucosidase (Skelly et The genomic structure of canine fucosidase was also determined and the introns partially sequenced. This information has been used to design intronic primers for amplification of exons for mutation analysis. PCR products were generated for each of the exons 2-8 using intronic primers. For each of these exons a single product was amplified which corresponded to the predicted size. SSCP analysis of these exons showed no differences between normal dogs, heterozygous dogs, and dogs known to have been homozygous for the fucosidosis allele (data not shown). Exon 1 was amplified in two parts. Difficulties were experienced in amplification of this exon, probably at least in part because of the G/C richness of both the exon and its surrounding introns. The 5' end of the exon, when amplified using PYu DNA polymerase and analysed by SSCP, showed no differences on PCR between normal, heterozygous, and homozygous mutant dogs. The 3' end of the exon could not be amplified cleanly.
SSCP analysis was performed across the majority of the cDNA sequence using RT-PCR. This analysis offibroblast and leucocyte mRNA from canine fucosidase normal and affected animals showed only one mobility shift, which was located in the 3' portion of exon 1 (fig 2) . This PCR product was cloned and sequenced in both normal and affected dogs and a 14 base pair deletion of the mRNA was identified at the 3' terminus of the exon ( fig 3A) . This deletion causes a frameshift within the transcript and a premature stop codon is produced downstream in exon 2. In the mutant cDNA, base 393 (EMBL accession number X92448) is now spliced to base 408 with a resultant frameshift in exon 2 of one nucleotide 5'. The mutant protein thus contains 25 novel amino acids before the first of two adjacent premature stop codons is encountered.
In order to determine the nature of this mutation in genomic DNA, amplification of the 3' end of exon 1 was performed on genomic DNA from an affected animal using the primers described (table, fig 1B) . As this PCR did not amplify with sufficient specificity, shotgun cloning of the size fractionated PCR products into pCR-II (Invitrogen) was necessary. Subsequent identification of the correct clone by sequence analysis allowed determination of the DNA sequence underlying the mutation. Surprisingly, this DNA also showed a deletion which was coextensive with that seen in the cDNA; that is, the final 14 base pairs of exon 1 were missing but the whole of intron 1 was present ( fig 3B) .
Discussion
In this paper we describe an alteration in the gene and transcript for the enzyme fucosidase in dogs suffering from fucosidosis. This deletion in the mRNA can be predicted to have major consequences in the subsequent translational processes because the frameshift induced by the deletion produces a premature termination codon. Hence 
